298 filings
8-K
DMKPQ
DMK Pharmaceuticals Corp
7 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
DMKPQ
DMK Pharmaceuticals Corp
5 Feb 24
Bankruptcy or Receivership
9:00am
8-K
DMKPQ
DMK Pharmaceuticals Corp
31 Jan 24
Submission of Matters to a Vote of Security Holders
5:17pm
8-K
DMKPQ
DMK Pharmaceuticals Corp
23 Jan 24
Material Modifications to Rights of Security Holders
5:22pm
8-K
DMKPQ
DMK Pharmaceuticals Corp
3 Jan 24
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
kurwf0o20l6f l42qv
3 Jan 24
Regulation FD Disclosure
5:00pm
8-K
m985lz
21 Dec 23
Termination of a Material Definitive Agreement
12:31pm
8-K
dohwbu0ulrsk ru
4 Dec 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
en405pbt kftbtdjtw5
28 Nov 23
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update
4:41pm
8-K
8281d0 hzy2gdkh
15 Nov 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
da9v0bppxds89
14 Nov 23
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
3:57pm
8-K
72sfev18l
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
269xg4yumx 4sqjl
17 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:37pm
8-K
6n0zqd
10 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:01am
8-K
hu0g28qb xgpbkz
8 Sep 23
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
4:50pm
8-K
2es7kz7g os5qa
1 Sep 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:45pm
8-K
f6bj7
29 Aug 23
Entry into a Material Definitive Agreement
4:30pm
8-K
cfnpf2nesu6nff116h46
21 Aug 23
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
5:20pm
8-K
qauoa96ukxcpepv
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
8-K
hyaqjcxp neyn
31 Jul 23
Completion of Acquisition or Disposition of Assets
5:13pm